Trilogy Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.05M | Sell |
|
|||||
|
2025
Q2 | $3.05M | Sell |
|
|||||
|
2025
Q1 | $3.73M | Sell |
|
|||||
|
2024
Q4 | $3.45M | Sell |
|
|||||
|
2024
Q3 | $3.44M | Sell |
|
|||||
|
2024
Q2 | $2.83M | Buy |
|
|||||
|
2024
Q1 | $2.79M | Buy |
|
|||||
|
2023
Q4 | $398K | Sell |
|
|||||
|
2023
Q3 | $403K | Sell |
|
|||||
|
2023
Q2 | $467K | Buy |
|
|||||
|
2023
Q1 | $419K | Sell |
|
|||||
|
2022
Q4 | $2.43M | Sell |
|
|||||
|
2022
Q3 | $1.91M | Buy |
|
|||||
|
2022
Q2 | $1.69M | Buy |
|
|||||
|
2022
Q1 | $1.26M | Buy |
|
|||||
|
2021
Q4 | $1.23M | Buy |
|
|||||
|
2021
Q3 | $1.13M | Buy |
|
|||||
|
2021
Q2 | $1.1M | Buy |
|
|||||
|
2021
Q1 | $638K | Buy |
|
|||||
|
2020
Q4 | $532K | Buy |
|
|||||
|
2020
Q3 | $574K | Sell |
|
|||||
|
2020
Q2 | $737K | Buy |
|
|||||
|
2020
Q1 | $637K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $244K | Sell |
|
|||||
|
2018
Q3 | $566K | Sell |
|
|||||
|
2018
Q2 | $579K | Sell |
|
|||||
|
2018
Q1 | $652K | Buy |
|